Key Researchers
 

 

Key Resources: Treating Opioid Addiction in an Office-Based Practice

Citations from Key Results

Auriacombe M, Franques P, Tignol J. Deaths attributable to methadone vs Buprenorphine in France. JAMA. 2001;285(1):45.
Brands J, Brands B, Marsh D. The expansion of methadone prescribing in Ontario, 1996-1998. Addict Res. 2000;8:485-496.
Fiellin DA, Pantalon MV, Chawarski MC, Moore BA, Sullivan LE, O'Connor PG, Schottenfeld RS. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. N Engl J Med. 2006 Jul 27;355(4):365-74.
Harris AH, Gospodarevskaya E, Ritter AJ. A randomised trial of the cost effectiveness of Buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting. Pharmacoeconomics. 2005;23(1):77-91.
King VL, Stoller KB, Hayes M, et al. A multicenter randomized evaluation of methadone medical maintenance. Drug Alcohol Depend. 2002;65(2):137-48.
McMurphy S, Shea J, Switzer J, Turner BJ. Clinic-based treatment for opioid dependence: a qualitative inquiry. Am J Health Behav. 2006;30(5):544-54.
Merrill JO, Jackson TR, Schulman BA, et al. Methadone medical maintenance in primary care. An implementation evaluation. J Gen Intern Med. 2005;20(4):344-9.
Merrill JO. Policy progress for physician treatment of opiate addiction. J Gen Intern Med. 2002;17(5):361-368.
Moore BA, Fiellin DA, Barry DT, et al. Primary care office-based Buprenorphine treatment: comparison of heroin and prescription opioid dependent patients. J Gen Intern Med. 2007;22(4):527-30.
Obadia Y, Perrin V, Feroni I, Vlahov D, Moatti JP. Injecting misuse of buprenorphine among French drug users. Addiction. 2001;96(2):267-72.
O'Connor PG, Oliveto AH, Shi JM, et al. A randomized trial of Buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. Am J Med. 1998;105(2):100-5.
Schackman BR, Merrill JO, McCarty D, Levi J, Lubinski C. Overcoming Policy and Financing Barriers to Integrated Buprenorphine and HIV Primary Care. Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S247-53.
Stein MD, Cioe P, Friedmann PD. Buprenorphine retention in primary care. J Gen Intern Med. 2005 Nov;20(11):1038-41.
Sullivan LE, Chawarski M, O'Connor PG, Schottenfeld RS, Fiellin DA. The practice of office-based Buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment? Drug Alcohol Depend. 2005;79(1):113-6.
Turner BJ, Laine C, Lin YT, Lynch K. Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or Buprenorphine for the management of opioid dependence. Arch Intern Med. 2005;165(15):1769-76.
Weinrich M, Stuart M. Provision of methadone treatment in primary care medical practices: review of the Scottish experience and implications for US policy. JAMA. 2000;283(10):1343-8.
 
Who We Are  | SAPRP Staff

SAPRP • One Leadership Place • Greensboro, NC 27410 • P: 336.286.4548 • F: 336.286.4434

A National Program supported by the Robert Wood Johnson Foundation with direction and technical assistance provided by the Center for Creative Leadership.
 
SAPRP Home SAPRP Knowledge Assets Home